253 related articles for article (PubMed ID: 32157927)
1. Effect of d-chiro-inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women.
Artini PG; Obino MER; Micelli E; Malacarne E; Vacca C; Papini F; Cela V
Gynecol Endocrinol; 2020 Sep; 36(9):755-759. PubMed ID: 32157927
[TBL] [Abstract][Full Text] [Related]
2. d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
Cianci A; Panella M; Fichera M; Falduzzi C; Bartolo M; Caruso S
Gynecol Endocrinol; 2015 Jun; 31(6):483-6. PubMed ID: 25893270
[TBL] [Abstract][Full Text] [Related]
3. Familial diabetes predisposes PCOS patients to insulin resistance (IR), reproductive impairment and hepatic dysfunction: effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index.
Genazzani AD; Battipaglia C; Petrillo T; Piacquadio N; Ambrosetti F; Arnesano M; Semprini E; Sponzilli A; Tomatis V; Simoncini T
Gynecol Endocrinol; 2022 Aug; 38(8):681-688. PubMed ID: 35748584
[No Abstract] [Full Text] [Related]
4. Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients.
Genazzani AD; Santagni S; Rattighieri E; Chierchia E; Despini G; Marini G; Prati A; Simoncini T
Gynecol Endocrinol; 2014 Jun; 30(6):438-43. PubMed ID: 24601829
[TBL] [Abstract][Full Text] [Related]
5. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
Genazzani AD; Prati A; Marchini F; Petrillo T; Napolitano A; Simoncini T
Gynecol Endocrinol; 2019 Dec; 35(12):1088-1093. PubMed ID: 31304823
[TBL] [Abstract][Full Text] [Related]
6. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
Mendoza N; Diaz-Ropero MP; Aragon M; Maldonado V; Llaneza P; Lorente J; Mendoza-Tesarik R; Maldonado-Lobon J; Olivares M; Fonolla J
Gynecol Endocrinol; 2019 Aug; 35(8):695-700. PubMed ID: 30880505
[TBL] [Abstract][Full Text] [Related]
8. Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.
O'Neill KE; Senapati S; Dokras A
Fertil Steril; 2015 Jan; 103(1):264-9. PubMed ID: 25450300
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
Cirillo F; Catellani C; Lazzeroni P; Sartori C; Tridenti G; Vezzani C; Fulghesu AM; Madeddu E; Amarri S; Street ME
Gynecol Endocrinol; 2020 Jul; 36(7):588-593. PubMed ID: 32054355
[TBL] [Abstract][Full Text] [Related]
10. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial.
Abdalmageed OS; Farghaly TA; Abdelaleem AA; Abdelmagied AE; Ali MK; Abbas AM
Reprod Sci; 2019 Oct; 26(10):1336-1342. PubMed ID: 29576001
[TBL] [Abstract][Full Text] [Related]
11. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
Cela V; Obino MER; Alberga Y; Pinelli S; Sergiampietri C; Casarosa E; Simi G; Papini F; Artini PG
Gynecol Endocrinol; 2018 Jun; 34(6):518-523. PubMed ID: 29271274
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
[TBL] [Abstract][Full Text] [Related]
13. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD
Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
[TBL] [Abstract][Full Text] [Related]
14. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
15. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
Regidor PA; Schindler AE; Lesoine B; Druckman R
Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction in polycystic ovary syndrome: Current options.
Legro RS
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():152-159. PubMed ID: 27866938
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
Chen ZJ; Shi YH; Li Y; Gao Q; Sheng Y; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):571-5. PubMed ID: 19087489
[TBL] [Abstract][Full Text] [Related]
18. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.
Rago R; Marcucci I; Leto G; Caponecchia L; Salacone P; Bonanni P; Fiori C; Sorrenti G; Sebastianelli A
J Biol Regul Homeost Agents; 2015; 29(4):913-23. PubMed ID: 26753656
[TBL] [Abstract][Full Text] [Related]
19. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome.
Fruzzetti F; Capozzi A; Canu A; Lello S
Gynecol Endocrinol; 2019 Jun; 35(6):506-510. PubMed ID: 30612488
[TBL] [Abstract][Full Text] [Related]
20. [Which ovarian stimulation to which women: The polycystic ovary syndrome (PCOS)].
Merviel P; Bouée S; Ménard M; Le Martelot MT; Roche S; Lelièvre C; Chabaud JJ; Jacq C; Drapier H; Beauvillard D
Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):623-631. PubMed ID: 29100822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
